OrganiGram Holdings Inc
TSX:OGI

Watchlist Manager
OrganiGram Holdings Inc Logo
OrganiGram Holdings Inc
TSX:OGI
Watchlist
Price: 1.93 CAD 1.58%
Market Cap: 258.4m CAD

EV/EBIT
Enterprise Value to EBIT

-2.5
Current
-2.1
Median
16.2
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-2.5
=
Enterprise Value
287.5m CAD
/
EBIT
-114.4m CAD
EBIT Growth EV/EBIT to Growth
CA
OrganiGram Holdings Inc
TSX:OGI
Average EV/EBIT: 1 875.7
Negative Multiple: -2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.9
14%
1.1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14.7
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197.1
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.9
11%
1
IE
E
Endo International PLC
LSE:0Y5F
739.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
11
10%
1.1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-12.9
2-Years Forward
EV/EBIT
-77
3-Years Forward
EV/EBIT
N/A